Stanford Health Policy is a joint effort of the Freeman Spogli Institute for International Studies and the Stanford School of Medicine
Encina Hall, Bechtel Conference Center
Panel Discussion followed by Keynote with Dr. Chelsea Clinton & Secretary Condoleezza Rice
Researchers analyzed three decades of sanctions on foreign aid to assess their impact on health. They hope the work can help government officials better understand and address how foreign policy decisions affect the well-being of local populations.
The Rosenkranz Global Health Policy Research Symposium at Stanford University will be held on Tuesday, May 16, 2023. The Symposium is a day-long event that showcases innovative global health policy research by academics from around the world. After the symposium, our keynote speaker will be Sheila Tlou, chancellor of Botswana Open University and the former minister of health for Botswana at the height of the HIV/AIDS epidemic. She currently is co-chair of the Global HIV Prevention Coalition and co-chair of the Nursing Now Global Campaign. Tlou, who has a PhD in community nursing from the University of Illinois at Chicago, helped launch the WHO’s State of the World Nursing Report in Geneva.
Her keynote address will focus on her personal experiences in translating and applying evidence-based decision-making to global health policy in the areas of gender, health, and HIV/AIDS. Following her talk, she will be in conversation with Michele Barry, director of the Stanford Center for Innovation in Global Health.
Agenda
Research Presentations (8:30 a.m. to 2:30 p.m., Reuben W. Hills Conference Room)
8:30 AM -9:10 AM: Jessica Cohen / Prompt(ed) Care: Experimental Evidence on a Maternal Digital Health Tool in Kenya
9:10 AM - 9:50 AM: Damian Clarke / Does Increasing Public Spending in Health Improve Health? Lessons from Constitutional Reform in Brazil
10:00 AM -10:40 AM: Eyal Frank / The Social Costs of Keystone Species Collapse: Evidence From The Decline of Vultures in India
10:40 AM - 11:20 AM: Marie Christelle Mabeu / Colonial Origins of Fertility Behaviors: Evidence on the Role of Forced Labor Migration in Burkina Faso
11:30 AM - 12:10 PM: Timothy Powell-Jackson / Management practices and quality of care: evidence from the private health care sector in Tanzania
12:10 PM-1:00 PM: Lunch
1:00 PM - 1:40 PM: Maria Rosales-Rueda / Social interventions, health and wellbeing: The long-term and intergenerational effects of a school construction program
1:40 PM - 2:20 PM:Antonella Bancalari / Public Service Delivery and Free Riding: Experimental Evidence from India
Keynote Address and Reception (3-5 p.m., Paul Brest Hall - East)
3:00 PM-4:15 PM: Keynote by Sheila Tlou followed by conversation with Michele Barry
4:15 PM-5:00 PM: Reception
Encina Hall (8:30 a.m. to 2:30 p.m.)
Reuben W. Hills Conference Room (2nd Floor, East Wing)
616 Jane Stanford Way, Stanford, CA 94305
Paul Brest Hall (3 p.m. to 5 p.m.)
555 Salvatierra Walk
Stanford, CA 94305
***
Stanford Medicine's new Department of Health Policy held its inaugural departmental symposium on October 6, convening thought leaders and experts in medicine, law, economics and data science. Speakers discussed innovative policy work and scalable solutions for improving health equity. Panelists addressed how to reduce persistent health disparities from three angles: social determinants of health, technology and innovation, and access and affordability.
Discover the powerful role health policy can serve in ensuring the health of all people, not just a privileged few.
***
Keynote Speaker: Kirsten Bibbins-Domingo, PhD, MD
Talk Title: Building Equity in the Research Enterprise
Opening Remarks by Stanford Medicine Dean Lloyd Minor
Terrance Mayes, Associate Dean for Equity and Strategic Initiatives
Panel 1 — Social Policy: Strategies for Addressing Structural Determinants of Health
Moderator
Alyce Adams, Stanford Medicine Innovation Professor, Professor of Epidemiology and Population Health, Professor of Health Policy
Panelists
Jeremy Goldhaber-Fiebert, Professor of Health Policy
Gilbert Gonzales, Assistant Professor at the Center for Medicine, Health & Society at Vanderbilt University
Adrienne Sabety, Assistant Professor of Health Policy
***
Panel 2 — Technology: Optimizing Innovation for Health Impact and Equity
Moderator: Josh Salomon, Professor of Health Policy, Director of the Prevention Policy Modeling Lab
Panelists
Joshua Makower, Boston Scientific Applied Biomedical Engineering Professor, Director of the Stanford Byers Center for Biodesign
Grant Miller, Henry J. Kaiser, Jr. Professor, Professor of Health Policy
Sherri Rose, Associate Professor of Health Policy, Co-Director of the Health Policy Data Science Lab
***
Panel 3 — Access & Affordability: How to Finance and Deliver Health Care Innovations Equitably
Moderator: Michelle Mello, Professor of Health Policy, Professor of Law
Panelists
Nicole Dickelson Cooper, Senior Vice President at UnitedHealth Group
Stacie Dusetzina, Associate Professor of Health Policy at Vanderbilt University Medical Center
Maria Polyakova, Assistant Professor of Health Policy
Vindell Washington, Chief Clinical Officer of Verily Health Platforms and CEO of Onduo
#StanfordHealthEquity
WATCH ENTIRE EVENT HERE
Learn More about Stanford Health Policy
Our People, Our Reserch and Our Mission to Improve Health
Advancing Health Equity Slideshow by Beth Duff-Brown
Accreditation
In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
American Medical Association (AMA)
Stanford Medicine designates this live activity for a maximum of 4.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
***
McCaw Hall, Arrillaga Alumni Center
Sherri Rose, PhD is an Associate Professor of Health Policy at the Stanford School of Medicine and Co-Director of the Health Policy Data Science Lab. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health and health equity. Within health policy, Dr. Rose works on risk adjustment, ethical algorithms in health care, comparative effectiveness research, and health program evaluation. She has published interdisciplinary projects across varied outlets, including Biometrics, Journal of the American Statistical Association, Journal of Health Economics, Health Affairs, and New England Journal of Medicine. In 2011, Dr. Rose coauthored the first book on machine learning for causal inference, with a sequel text released in 2018. She has been Co-Editor-in-Chief of the journal Biostatistics since 2019.
Dr. Rose has been honored with an NIH Director's New Innovator Award, the ISPOR Bernie J. O'Brien New Investigator Award, and multiple mid-career awards, including the Gertrude M. Cox Award and the Mortimer Spiegelman Award, the nation’s highest honor in biostatistics, given to a statistician younger than 40 who has made the most significant contributions to public health statistics. She was named a Fellow of the American Statistical Association in 2020 and received the 2021 Mortimer Spiegelman Award, which recognizes the statistician under age 40 who has made the most significant contributions to public health statistics. Her research has been featured in The New York Times, USA Today, and The Boston Globe.
Title: New and Ongoing Projects at the Interface of Machine Learning for Health Policy
Encina Commons,
615 Crothers Way
Stanford, CA 94305-6006
Sherri Rose, Ph.D. is a Professor of Health Policy and, by courtesy, of Computer Science at Stanford University, where she is Director of the Health Policy Data Science Lab. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health and health equity. Within health policy, Dr. Rose works on ethical algorithms in health care, risk adjustment, chronic kidney disease, and health program evaluation. She has published interdisciplinary projects across varied outlets, including Biometrics, Journal of the American Statistical Association, Journal of Health Economics, Health Affairs, and New England Journal of Medicine. In 2011, Dr. Rose coauthored the first book on machine learning for causal inference, with a sequel text released in 2018.
Dr. Rose has been honored with an NIH Director’s Pioneer Award, NIH Director's New Innovator Award, the ISPOR Bernie J. O'Brien New Investigator Award, and multiple mid-career awards, including the Gertrude M. Cox Award. She is a Fellow of the American Statistical Association (ASA) and received the Mortimer Spiegelman Award, which recognizes the statistician under age 40 who has made the most significant contributions to public health statistics. In 2024, she received both the ASHEcon Willard G. Manning Memorial Award for Best Research in Health Econometrics and the ASA Outstanding Statistical Application Award. She was recently awarded the Open Science Champion Prize by Stanford University. Her research has been featured in The New York Times, USA Today, and The Boston Globe. She was Co-Editor-in-Chief of the journal Biostatistics from 2019-2023.
She received her Ph.D. in Biostatistics from the University of California, Berkeley and a B.S. in Statistics from The George Washington University before completing an NSF Mathematical Sciences Postdoctoral Research Fellowship at Johns Hopkins University.
Title: Customer Discrimination and Quality Signals: A Field Experiment with Healthcare Shoppers
Abstract: This paper provides evidence that customer discrimination in the market for doctors can be largely accounted for by statistical discrimination. I evaluate customer preferences in the field with an online platform where cash-paying consumers can shop and book a provider for medical procedures based on an experimental paradigm called validated incentivized conjoint analysis (VIC). Customers evaluate doctor options they know to be hypothetical to be matched with a customized menu of real doctors, preserving incentives. Racial discrimination reduces patient willingness-to-pay for black and Asian providers by 12.7% and 8.7% of the average colonoscopy price respectively; customers are willing to travel 100–250 miles to see a white doctor instead of a black doctor, and somewhere between 50–100 to 100–250 miles to see a white doctor instead of an Asian doctor. Further, providing signals of provider quality reduces this willingness-to-pay racial gap by about 90%, which suggests that statistical discrimination is an important cause of the gap. Actual booking behavior allows cross-validation of incentive compatibility of stated preference elicitation via VIC.
Alex Chan is a PhD candidate in Health Economics, and a Gerhard Casper Stanford Graduate Fellow. He has research interests in health economics, experimental economics, market design, and labor economics. His projects look at the causes and consequences of discrimination and diversity in medicine, U.S. Health Policy (especially organ transplantation), and market design in health policy and medicine. He holds an MPH from Harvard University. Before Stanford, he developed extensive experience in the healthcare industry starting as a McKinsey consultant, and most recently as Senior Vice President of Market Strategy with Optum/UnitedHealth before joining academia.
Personal Website: https://www.alexchan.net
Register in advance for this meeting:
https://stanford.zoom.us/meeting/register/tJEsdOGppjMtGtPVKFHk0vX_TMCK5PzMa_Mv
After registering, you will receive a confirmation email containing information about joining the meeting.
Alex Chan graduated with a PhD in 2023.
Alexander M. Nick Professor
Associate Professor of Business Economics and Public Policy
University of Michigan, Ross Schoo lof Business
Stay Tuned for Details
Associate Professor of Strategy at the Kellogg School of Management
Faculty Research Fellow at the National Bureau of Economic Research (NBER)
Professor Amanda Starc received her BA in Economics from Case Western Reserve University, and her PhD in Business Economics from Harvard University. Dr. Starc's research interests include industrial organization and health economics. Her research examines the Medicare Advantage, Medicare Part D, and Medicare Supplement ("Medigap") markets, as well as consumer behavior in insurance exchanges. Recent work measures the effectiveness of direct-to-consumer advertising of pharmaceuticals. Her work links models of consumer choice and supply side incentives, and uses a range of econometric techniques to analyze data.
This will be an in-person event: Encina Commons, Conference Rom 119, with a boxed lunch served.
Jiayi Zhao graduated with a MS student in Health Policy (Empirical Methods) in 2023. She has research interests in causal inference, machine learning, health economics, and policy evaluation, especially health issues in aging societies. Her prior research experience includes work in disability, long term care, and aging. She holds a BS in statistics and finance from the University of Hong Kong and MS in social policy and data analytics from the University of Pennsylvania.
Masahiro works for the Ministry of Health, Labor, Welfare, Japan. He has been in charge of national long-term care insurance especially its finance and health program for the elderly. Previously, after graduating from Tokyo University with a BA in Economics, he was in charge of the national health insurance system and its payment for medical services.
